U.S. RESEARCH ROUNDUP- Amgen, Cree, Roper Technologies

Mammoth Energy Services

27/08/2019 08:18

Aug 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Amgen, Cree and Roper Technologies on Tuesday. 
    
  HIGHLIGHTS
     * Amgen Inc  AMGN.O : RBC raises price target to $206 from $192
     * Cree Inc  CREE.O : JP Morgan raises to neutral from underweight
     * Roper Technologies Inc  ROP.N : RBC raises price target to $404 from $393
       
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order.
    
     * Amgen Inc  AMGN.O : RBC raises price target to $206 from $192
     * Caleres Inc  CAL.N : Susquehanna raises price target to $20 from $18
     * Carlyle Group LP  CG.O : JP Morgan raises price target to $32 from $31
     * Cree Inc  CREE.O : JP Morgan raises to neutral from underweight
     * Denali Therapeutics  DNLI.O : JP Morgan establishes Dec-20 TP of $22 vs Dec 2019 TP of $23
     * Dick's Sporting Goods Inc  DKS.N : Evercore ISI cuts price target to $35 from $40
     * Gaslog Partners LP  GLOP.N : Evercore ISI cuts price target to $24 from $25
     * Golar Lng Ltd  GLNG.O : Evercore ISI cuts price target to $31 from $35
     * Golar Lng Partners LP  GMLP.O : Evercore ISI cuts price target to $15 from $16
     * Hewlett Packard Enterprise Co  HPE.N : Evercore ISI cuts price target to $13 from $14
     * Medicines Co  MDCO.O : Oppenheimer raises price target to $52 from $48
     * Mednax Inc  MD.N : Credit Suisse cuts price target to $28 from $30
     * Pioneer Natural Resources Co  PXD.N : JP Morgan cuts price target to $154 from $166
     * Roper Technologies Inc  ROP.N : RBC raises price target to $404 from $393
     * SRC Energy Inc  SRCI.N : RBC cuts price target to $5 from $6
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))